MDPI and ACS Style
Alonso, J.C.C.; de Souza, B.R.; Reis, I.B.; de Arruda Camargo, G.C.; de Oliveira, G.; de Barros Frazão Salmazo, M.I.; Gonçalves, J.M.; de Castro Roston, J.R.; Caria, P.H.F.; da Silva Santos, A.;
et al. OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway. Int. J. Mol. Sci. 2023, 24, 17535.
https://doi.org/10.3390/ijms242417535
AMA Style
Alonso JCC, de Souza BR, Reis IB, de Arruda Camargo GC, de Oliveira G, de Barros Frazão Salmazo MI, Gonçalves JM, de Castro Roston JR, Caria PHF, da Silva Santos A,
et al. OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway. International Journal of Molecular Sciences. 2023; 24(24):17535.
https://doi.org/10.3390/ijms242417535
Chicago/Turabian Style
Alonso, João Carlos Cardoso, Bianca Ribeiro de Souza, Ianny Brum Reis, Gabriela Cardoso de Arruda Camargo, Gabriela de Oliveira, Maria Izabel de Barros Frazão Salmazo, Juliana Mattoso Gonçalves, José Ronaldo de Castro Roston, Paulo Henrique Ferreira Caria, André da Silva Santos,
and et al. 2023. "OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway" International Journal of Molecular Sciences 24, no. 24: 17535.
https://doi.org/10.3390/ijms242417535